Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent Biosolutions Non-GAAP EPS of $4.50 beats by $0.08, revenue of $723.2M beats by $46.28M
09:14pm, Thursday, 24'th Feb 2022 Seeking Alpha
Emergent Biosolutions press release (EBS): Q4 Non-GAAP EPS of $4.50 beats by $0.08.Revenue of $723.2M (+24.0% Y/Y) beats by $46.28M.Updated FY 2022 Guidance: Revenue now expected…
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
01:01pm, Thursday, 24'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Adagio Appoints COO David Hering As Interim CEO
Adagio Therapeutics, Inc., (NASDAQ: ADGI) announced th
Emergent Biosolutions Q4 2021 Earnings Preview (NYSE:EBS)
10:35pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Emergent Biosolutions (NYSE:EBS) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $4.42 (+20.4% Y/Y) and…
Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More
04:44pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24.
Endo (ENDP) to Report Q4 Earnings: What's in the Cards?
03:11pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Endo's (ENDP) fourth-quarter earnings might have gained from higher sales of Xiaflex.
Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More
01:06pm, Wednesday, 23'rd Feb 2022
Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24.
Viatris (VTRS) to Report Q4 Earnings: What's in the Cards?
03:19pm, Tuesday, 22'nd Feb 2022 Zacks Investment Research
Viatris' (VTRS) Q4 earnings might have gained from the solid performance of Lipitor, Influvac, Viagra and EpiPen.
What's in the Cards for Bausch Health (BHC) Q4 Earnings?
03:43pm, Monday, 21'st Feb 2022 Zacks Investment Research
An update on the IPO of Bausch+Lomb and regular top-line and bottom-line numbers will grab investors' attention when BHC reports Q4 results.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
01:06pm, Sunday, 20'th Feb 2022 Benzinga
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
On the regulatory front, the Food and Drug A
Emergent BioSolutions: Still A Bargain Regardless Of Diminished Growth Forecasts
05:26pm, Sunday, 13'th Feb 2022 Seeking AlphaEmergent BioSolutions: Still A Bargain Regardless Of Diminished Growth Forecasts
12:26pm, Sunday, 13'th Feb 2022
Emergent BioSolutions has been an exiled ticker following the vaccine mix-up at the company's Bayview Facility last year. Although the company has addressed the issues in Bayview, it looks as if the m
Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022
11:30am, Monday, 07'th Feb 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financia
Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022
11:30am, Monday, 07'th Feb 2022 GlobeNewswire
GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financial results for the fourth quarter 2021, recent business developments, financial outlook for full year 2022, and revenue guidance for the first quarter of 2022.
Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022
06:30am, Monday, 07'th Feb 2022
GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financial
4 Companies Growing Earnings Fast
04:56pm, Sunday, 06'th Feb 2022
The S&P 500 saw the trailing 12-month real earnings per share of its member companies increase by a compound annual growth rate of 11.6% over the past five years. The index, which stood at a price of
